Evidence map›Paper›PMID 42743233›Full record

ArticlePloS one2026

Comparative phytochemical profiling and bioactivity evaluation of three Indonesian pomegranate (Punica granatum) peel varieties: Antioxidant, antibacterial, and in vitro antiproliferative activities.

Triono Bagus Saputro, Aulia Sunan Fadilah, Anisatus Solihah, Awik Puji Dyah Nurhayati, Panita Chutimanukul, Hamdan Dwi Rizqi

Abstract readComparative Study
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Triono Bagus SaputroDepartment of Biology, Faculty of Science and Data Analytics, Institut Teknologi Sepuluh Nopember, Surabaya, Jawa Timur, Indonesia.ORCID https://orcid.org/0000-0002-8414-1438
Aulia Sunan FadilahDepartment of Biology, Faculty of Science and Data Analytics, Institut Teknologi Sepuluh Nopember, Surabaya, Jawa Timur, Indonesia.
Anisatus SolihahDepartment of Biology, Faculty of Science and Data Analytics, Institut Teknologi Sepuluh Nopember, Surabaya, Jawa Timur, Indonesia.
Awik Puji Dyah NurhayatiDepartment of Biology, Faculty of Science and Data Analytics, Institut Teknologi Sepuluh Nopember, Surabaya, Jawa Timur, Indonesia.
Panita ChutimanukulNational Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency, Khlong Luang, Pathum Thani, Thailand.
Hamdan Dwi RizqiDepartment of Chemistry, Faculty of Science and Data Analytics, Institut Teknologi Sepuluh Nopember, Surabaya, Jawa Timur, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antioxidants are compounds that inhibit, prevent, and reduce free radical activity caused by reactive oxygen species (ROS), thereby protecting cells from oxidative damage. Pomegranate (Punica granatum L.) is recognized as a valuable source of antioxidants, largely due to the phenolic and flavonoid compounds concentrated in its peel. Variations in cultivar, geographical region, and extraction methods are known to influence its bioactive composition. This study aimed to analyze the antioxidant capacity of the exocarp and mesocarp of three pomegranate varieties (red, yellow, and purple), grown in Indonesia, characterized by their different peel colors, extracted using ethanol (96%) and n-hexane, analyzed separately with total phenolic content (TPC), total flavonoid content (TFC), ABTS, and DPPH assays. The results showed variation in antioxidant capacity and biological compounds depending on both plant tissue and solvent used. Ethanolic extracts generally yielded higher phenolic and flavonoid contents, with the purple exocarp recording the highest TPC (721 mg GAE g-1) and TFC (161 mg QE g-1). In contrast, n-hexane extracts produce a lower yield, with the red mesocarp as the richest in bioactive compounds, with TPC (70.21 mg GAE g-1) and TFC (12.07 mg QE g-1). The ethanolic extracts consistently exhibited markedly stronger antioxidant activity, reflected by low IC50 values in both ABTS and DPPH assays, with the purple pomegranate exocarp showing the highest potency (IC50 value < 50 μg mL-1), followed by the red and yellow varieties. In contrast, n-hexane extracts demonstrated substantially weaker activity, indicated by IC50 > 200 ppm. Phytochemical profiling through LC-HRMS revealed the presence of diverse polar antioxidants, including phenolic acids, flavonoid glycosides, and anthocyanin derivatives, particularly abundant in the purple peel. Complementary GC-MS analysis confirmed the presence of non-polar constituents such as fatty acids, sterols, terpenoids, and other lipophilic metabolites. The antibacterial activity of the ethanolic peel extracts was evaluated against Staphylococcus aureus and Escherichia coli using the broth microdilution method, revealing inhibitory effects across all varieties with IC50 values ranging from 1417.41 to 5063.08 µg mL-1. The ethanolic extract of yellow pomegranate mesocarp exhibited the strongest antibacterial activity, while the ethanolic extract of yellow pomegranate exocarp showed the weakest inhibition. In the MTT assay, all ethanolic extracts of pomegranate peel from three varieties demonstrated antiproliferative effects against Huh7it cells after 48 h incubation. Notably, the purple pomegranate exocarp showed the highest cytotoxic potency (IC50 = 231.22 µg mL-1). This research can be used as initial information about new sources of antioxidants.

Indexed as

Anti-Bacterial AgentsAntioxidantsPhytochemicalsPlant ExtractsPomegranateCell ProliferationFlavonoidsFruitHumansIndonesiaMicrobial Sensitivity TestsPhenolsAnti-Bacterial AgentsAntioxidantsFlavonoidsPhenolsPhytochemicalsPlant Extracts

Identifiers

PMID42743233
PMCPMC13577413

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.